Recruiting Systemic Mastocytosis Studies in Birmingham
About Systemic Mastocytosis Clinical Trials in Birmingham
Systemic mastocytosis is a rare condition caused by accumulation of abnormal mast cells in the bone marrow, skin, liver, spleen, and GI tract. It can cause allergic reactions, bone pain, and organ damage. Treatment includes targeted therapies, antihistamines, and mast cell stabilizers.
There are currently 3 systemic mastocytosis clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 1,424 participants. Research is being sponsored by Blueprint Medicines Corporation, Cogent Biosciences, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Systemic Mastocytosis Clinical Trials in Birmingham — FAQ
Are there systemic mastocytosis clinical trials in Birmingham?
Yes, there are 3 systemic mastocytosis clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Birmingham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.
Are clinical trials in Birmingham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.
What systemic mastocytosis treatments are being tested?
The 3 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for systemic mastocytosis.
Data updated August 28, 2026 from ClinicalTrials.gov